As T cells and CAFs, the main source of CD47 in the melanoma model, are predominantly located at the tumor edge along the boundary with healthy tissue, it is likely that engagement of CD47 by myeloid cells occurs as the cells first enter the tumor before they penetrate the core. This evidence concerns the gene CD47 and melanoma.